Your browser doesn't support javascript.
loading
Li Fraumeni syndrome, cancer and senescence: a new hypothesis.
Pantziarka, Pan.
Afiliación
  • Pantziarka P; The George Pantziarka TP53 Trust, London, UK. anticancer.org.uk@gmail.com.
Cancer Cell Int ; 13(1): 35, 2013 Apr 15.
Article en En | MEDLINE | ID: mdl-23587008
ABSTRACT
Li Fraumeni Syndrome (LFS) is a rare autosomal dominant hereditary cancer syndrome characterized by germline mutations in the TP53 tumour suppressor gene. Sufferers are prone to early onset cancers, particularly sarcomas, adrenocortical carcinoma and breast cancer. Cells from LFS sufferers are known to exhibit telomere dysfunction, genomic instability and spontaneous immortalisation. It is hypothesized that these facets of the LFS host are evidence that the host environment is "primed" for carcinogenesis over and above the lack of p53 tumour suppressor function. Further, it is hypothesized that the host presents an ideal environment for "two compartment tumour metabolism" to take place. Evidence from recent studies supports this new view of LFS and suggests that disrupting certain features of the host environment may markedly reduce the incidence of cancer in LFS sufferers.

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Cancer Cell Int Año: 2013 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Cancer Cell Int Año: 2013 Tipo del documento: Article País de afiliación: Reino Unido